Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01526837
Title Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Brain & Spine Surgeons of New York
Age Groups: adult
Covered Countries USA

No variant requirements are available.